Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Liting Guo,1,* Haijun Zhang,1,* Weiwei Shao,2 Baoan Chen1 1Department of Hematology and Oncology (Key Department of Jiangsu Medicine), The Affiliated Zhongda Hospital, Medical School of Southeast University, Nanjing, 2Department of Pathology, the First People’s Hospital of Yancheng, Yanch...

Full description

Bibliographic Details
Main Authors: Guo L, Zhang H, Shao W, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:Drug Design, Development and Therapy
Online Access:https://www.dovepress.com/crizotinib-as-a-personalized-alternative-for-targeted-anaplastic-lymph-peer-reviewed-article-DDDT

Similar Items

Similar Items